Further reports demonstrated that PD-1/PD-L1 can regulate the Th9 tumor-infiltrating lymphocytes (TILs) in CRC and drive the CD8+ T-cell expansion but not CD4+ T-cell (140). This evidence concerns the gene CD8A and colorectal carcinoma.